Propanc Biopharma, Inc.
PPCB· Nasdaq
PPCBPropanc Biopharma, Inc.
Filed Nov 19, 2012 · 10-Q · 50 days after period end · 0001354488-12-006039
| Metric | Q1 2013 | Q1 2012 |
|---|---|---|
| Net Income | -$492.68K | -$3.07M |
| EPS Diluted | -$0.01 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Propanc Biopharma, Inc. · CIK 1517681 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 19, 2012 · 50 d after period end
